Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
Abstract Background The pharmaceutical industry is in the midst of a productivity crisis and rates of translation from bench to bedside are dismal. Patients are being let down by the current system of drug discovery; of the several 1000 diseases that affect humans, only a minority have any approved...
Main Authors: | Pandora Pound, Merel Ritskes-Hoitinga |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1678-1 |
Similar Items
-
Reporting of 3Rs Approaches in Preclinical Animal Experimental Studies—A Nationwide Study
by: Birgitte S. Kousholt, et al.
Published: (2023-09-01) -
The impact of conducting preclinical systematic reviews on researchers and their research: A mixed method case study.
by: Julia M L Menon, et al.
Published: (2021-01-01) -
Recommendations for robust and reproducible preclinical research in personalised medicine
by: Vibeke Fosse, et al.
Published: (2023-01-01) -
Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies
by: Merel Ritskes-Hoitinga, et al.
Published: (2020-07-01) -
INTERNAL AND EXTERNAL RELEVANCE OF SPEECH INTERACTION IN THE CONTEXT OF PARLIAMENTARY DELIBERATION
by: Galina E. Popova
Published: (2022-01-01)